Cross-docking and molecular dynamic studies to achieve the potent antiviral HIV-1 nonnucleoside reverse transcriptase inhibitors. Science Essence Journal, [S. l.], v. 39, n. 2, p. 23–37, 2023. Disponível em: https://ejournals.swu.ac.th/sej/article/view/15577. Acesso em: 23 oct. 2026.